SYK Stryker Corporation logo

SYK Stryker Corporation

Healthcare
$316.48+0.95%ClosedMarket Cap: $121.33B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

39.15

PEG

4.63

P/B

5.43

P/S

4.80

EV/EBITDA

22.94

DCF Value

$318.34

FCF Yield

3.8%

Div Yield

1.1%

Margins & Returns

Gross Margin

63.7%

Operating Margin

21.3%

Net Margin

13.2%

ROE

15.2%

ROA

7.2%

ROIC

9.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$6.02B$745.0M$
Q4 null$7.17B$849.0M$
FY null$25.12B$3.25B$
Q3 null$6.06B$859.0M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$385.83

Target (Median)

$389.50

Target Range

$315.00 - $465.00

8 Strong Buy14 Buy7 Hold0 Sell0 Strong Sell
BarclaysOverweight
2026-05-04
Truist SecuritiesHold
2026-05-04
JP MorganOverweight
2026-05-01
NeedhamBuy
2026-05-01
Evercore ISI GroupOutperform
2026-05-01

Trading Activity

Insider Trades

View All
Fink M Kathrynofficer: VP, Chief HR Officer
SellTue May 12
Fink M Kathrynofficer: VP, Chief HR Officer
SellTue May 12
Fink M Kathrynofficer: VP, Chief HR Officer
SellTue May 12
Fink M Kathrynofficer: VP, Chief HR Officer
SellTue May 12
Fink M Kathrynofficer: VP, Chief HR Officer
SellTue May 12

Congress Trades

View All
Ro KhannaBuy
Wed May 13

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.81

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Peers